PCSK9 and Parkinson disease: However, HMGCR inhibitors increased the risk of PD (OR [95%] = 1.907 [1.502 to 2.312], p = 0.001).<h4>Conclusion</h4>PCSK9 inhibitors significantly reduce the risk of ALS but increase the risk of PD.